Delivery Order SPE2DB22D1041-SPE2DB24FUDR8

Award Date 9/10/24
Potential Completion Date 9/11/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $2,242.95 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,133,907 units of Epinephrine 0.3 mg auto-injectors. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support...
The U.S. Defense Logistics Agency (DLA) awarded a $8,497.78 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,764,629 units of Epinephrine 0.3 mg auto-injectors. This is a child contract under AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive vehicle for supplying a range of pharmaceutical products and medical supplies to support...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,592.15 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,727,625 units of Epinephrine 0.3 mg auto-injector 2-packs. The contract has a firm fixed price and an ultimate completion date of December 17, 2024. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM.gov), is the prime contractor with no set-aside designation...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $2,730.69 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,564,675,611 units of epinephrine 0.15 mg auto-injectors. The contract has a firm fixed price and an ultimate completion date of May 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
The U.S. Defense Logistics Agency (DLA) awarded a $1,373.67 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,556,974,597 units of Epinephrine 0.3 mg auto-injectors. This contract has an ultimate completion date of April 25, 2022 and was not designated with a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a $9,457.90 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,122,803 units of EPINEPHRINE 0.3 MG AUTO-INJECT 2S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,209.24 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of EPINEPHRINE 0.3 MG AUTO-INJECT 2S. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, to provide 4,558,239,096 units of Epinephrine 0.3 mg auto-injectors. The $7,187.12 firm fixed-price contract has an ultimate completion date of August 29, 2022 and was awarded on August 26, 2022. This order is part of Amerisourcebergen's existing $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
The U.S. Defense Logistics Agency (DLA) awarded a $7,279.85 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,735,813 units of EPINEPHRINE 0.3 MG AUTO-INJECT 2S. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of medical commodities to support military treatment programs and...
The Defense Logistics Agency (DLA) awarded a $16,563.32 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation for the supply of 4,565,661,114 units of Epinephrine 0.3 mg Auto-Injectors. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. AmerisourceBergen, a...
  • SPE2DB22D1041
    Indefinite Delivery Contract
  • SPE2DB22D1041-SPE2DB24FUDR8
    Delivery Order

The Defense Logistics Agency (DLA) awarded a $1,550.76 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,749,613 units of epinephrine 0.3 mg auto-injector 2-packs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to supply a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has an ultimate completion date of September 11, 2024 and does not utilize any set-aside designations.

Generated 12/10/24, 2:29 PM